EXACT Sciences
EXASExact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer. Exact Sciences Corp. launched Cologuard in 2014, the first stool DNA test for colorectal cancer. The company was founded in 1995 in Marlborough, Massachusetts, bu …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at EXACT Sciences
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 11/13/2024 | Buy | Conroy, Kevin T. | President and CEO | $51.4 | $1,001,325 |
| 10/8/2024 | Sell | Baranick, Brian | EVP, GM, Precision Oncology | $70.0 | $65,030 |
| 9/18/2024 | Sell | Baranick, Brian | EVP, GM, Precision Oncology | $70.0 | $65,030 |
| 5/1/2024 | Sell | Elliott, Jeffrey Thomas | Chief Financial Officer | $60.2 | $8,180 |
| 5/1/2024 | Sell | Condella, Sarah | EVP, Human Resources | $60.2 | $6,135 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)